Advance the Process
GKD is overhauling the diagnostic process to improve outcomes for both patients and physicians. With point-of-care testing and fast results across a suite of various diagnostics, our MultiNostic Test Kit improves the quality of care while also addressing the cost of care.
Today, patients travel to an outside lab to have diagnostic testing conducted. Then, providers must wait for the lab to report those test results before they can make an accurate diagnoses and formulate a treatment plan. This system inhibits quick and early treatment for patients, which can allow health problems to worsen.
New Clinical Partner - GKD and the Lehigh Valley Health Network Laboratories have announced a clinical partnership
Growth and Expansion - GKD expanded its research team and enhanced its lab and manufacturing facilities to meet the demands of its partnerships and product development pipeline
AACC - GKD attended this year’s AACC conference to highlight its research developments, network and attend business meetings with industry leaders
GKD in the News
2019 Technical.ly Awards Nomination
Group K Diagnostics has been nominated for Technical.ly’s “Startup of the Year” Award alongside a handful of incredible companies from around the Philly area. Click the link below to cast your vote for GKD!
CDC, Group K Diagnostics Ink Deal to Design Zika Virus Test
GKD has partnered with the CDC to begin working on a point-of-care Zika Virus Test using our microfluidic test strip technology.
GKD, Health Network Laboratories Commence Clinical Trial for Liver Function Test
The partners plan to validate the accuracy, effectiveness, and clinical implications of Group K's MultiNostic liver function test, which is pending FDA clearance.